Technical Analysis for GALT - Galectin Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 2.56 -4.83% -0.13
GALT closed down 4.83 percent on Friday, February 21, 2020, on 65 percent of normal volume.
Earnings due: Mar 4
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GALT trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 20 DMA Bullish -4.83%
MACD Bullish Signal Line Cross Bullish -4.83%
Stochastic Buy Signal Bullish -4.83%
Pocket Pivot Bullish Swing Setup -4.83%
Outside Day Range Expansion -4.83%
Oversold Stochastic Weakness -4.83%
MACD Bearish Signal Line Cross Bearish 1.19%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Cancer Tumor Hepatitis Therapies For Cancer Non Alcoholic Fatty Liver Disease Steatohepatitis Lectins Liver Fibrosis Europe Galectin Galectin 3

Is GALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.65
52 Week Low 2.5
Average Volume 208,447
200-Day Moving Average 3.51
50-Day Moving Average 2.80
20-Day Moving Average 2.64
10-Day Moving Average 2.61
Average True Range 0.14
ADX 14.77
+DI 21.37
-DI 19.95
Chandelier Exit (Long, 3 ATRs ) 2.52
Chandelier Exit (Short, 3 ATRs ) 2.92
Upper Bollinger Band 2.84
Lower Bollinger Band 2.44
Percent B (%b) 0.3
BandWidth 15.14
MACD Line -0.07
MACD Signal Line -0.08
MACD Histogram 0.0071
Fundamentals Value
Market Cap 89.73 Million
Num Shares 35.1 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -4.20
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.82
Resistance 3 (R3) 2.84 2.78 2.77
Resistance 2 (R2) 2.78 2.72 2.77 2.76
Resistance 1 (R1) 2.67 2.67 2.64 2.65 2.74
Pivot Point 2.61 2.61 2.60 2.60 2.61
Support 1 (S1) 2.50 2.55 2.47 2.48 2.38
Support 2 (S2) 2.44 2.50 2.43 2.36
Support 3 (S3) 2.33 2.44 2.35
Support 4 (S4) 2.31